Mestastop® Solutions

Stopping Metastasis, giving life a second chance

Founded 2018

United States 18 employees Seed Total: $58.00M Biotechnology, Life Sciences

Mestastop® Solutions is a biotechnology startup founded in 2018, with its headquarters in the United States. The company's slogan, "Stopping Metastasis, giving life a second chance," highlights its dedication to addressing one of the most critical aspects of cancer. Mestastop focuses on combating metastasis, which is responsible for almost 90% of cancer deaths. Despite advancements in cancer treatment such as targeted therapy and immunotherapy, addressing metastasis remains a significant challenge in the field. Mestastop aims to fill this gap with its unique proprietary platforms, including METAssay, METSCAN, and METVivo. These platforms target the challenges faced in advancing a molecule targeting metastasis, from suitable in vitro models to animal models that closely resemble the biology without alleviating cost and timelines. In line with its mission, Mestastop recently secured a Seed Round investment of INR45.00M on 19 October 2023, with 92 Angels and Malpani Ventures as the participating investors. This funding is a testament to the potential of Mestastop's innovative approach to combating metastasis and reflects investor confidence in the company's ability to make a significant impact in the biotechnology sector.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	INR45.00M	2	92 Angels, Malpani Ventures	19 Oct 2023
Seed Round	INR13.00M	2	IIMA Ventures, IKP Knowledge Park	19 Oct 2021
Seed Round	Undisclosed	1	Mumbai Angels	22 Sep 2020

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

INR45.00M

92 Angels, Malpani Ventures

19 Oct 2023

Seed Round

INR13.00M

IIMA Ventures, IKP Knowledge Park

19 Oct 2021

Seed Round

Undisclosed

Mumbai Angels

22 Sep 2020

FAQ About Mestastop® Solutions

Stopping Metastasis, giving life a second chance

Mestastop® Solutions was founded in 2018.

Mestastop® Solutions is headquartered in United States.

Mestastop® Solutions operates in Biotechnology and Life Sciences. Its work centres on cancer treatment, metastasis, drug discovery and anti-metastasis.

Mestastop® Solutions has approximately 18 employees.

Mestastop® Solutions has completed 3 funding rounds, raising a total of $58.00M. The latest funding stage is Seed.

Top alternatives and competitors to Mestastop® Solutions include Sensei Bio, VitroScan, Seekyo Therapeutics, Bicara Therapeutics, Outpace Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Mestastop® Solutions and Sensei Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Mestastop® Solutions

Funding Rounds & Investors (3)

Mestastop® Solutions Alternatives & Competitors

FAQ About Mestastop® Solutions